Evidence map›Paper›PMID 34145845›Full record

ArticleBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences2021

[Effectiveness of different screening strategies for cardiovascular diseases prevention in a community-based Chinese population: A decision-analytic Markov model].

Q P Liu, X J Chen, J M Wang, X F Liu, Y Q Si, J Y Liang, P Shen, H B Lin, X Tang, P Gao

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Q P LiuDepartment of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.
X J ChenCenter for Real-world Evidence Evaluation, Peking University Clinical Research Institute, Beijing 100191, China.
J M WangDepartment of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.
X F LiuCenter for Real-world Evidence Evaluation, Peking University Clinical Research Institute, Beijing 100191, China.
Y Q SiDepartment of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.
J Y LiangDepartment of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.
P ShenYinzhou District Center for Disease Control and Prevention, Ningbo 315101, Zhejiang, China.
H B LinYinzhou District Center for Disease Control and Prevention, Ningbo 315101, Zhejiang, China.
X TangDepartment of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.
P GaoDepartment of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the potential effectiveness of different screening strategies for cardiovascular diseases prevention in a community-based Chinese population from economically developed area of China.

methodsTotally 202 179 adults aged 40 to 74 years without cardiovascular diseases at baseline (January 1, 2010) were enrolled from the Chinese electronic health records research in Yinzhou (CHERRY) study. Three scenarios were considered: the screening strategy based on risk charts recommended by the 2020

resultsCompared with non-screening strategy, QALYs gained were 1 433 [95% uncertainty interval (

conclusionScreening for cardiovascular diseases in Chinese adults aged above 40 years seems effective in coastal developed areas of China, and the different screening strategies based on risk charts by the 2020

Indexed as

Cardiovascular DiseasesAdultChinaCost-Benefit AnalysisHumansMass ScreeningPrimary PreventionQuality-Adjusted Life YearsCardiovascular diseasesMarkov modelScreening

Identifiers

PMID34145845
PMCPMC8220034
OpenAlexW3168492028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.